The former biotech CEO referred to as “The Most Hated Man in America” was in court today for his upcoming trial for fraud.
Earlier this week, we reported on interest that Shire was showing in Baxalta. Now, Baxalta stock is plunging almost 30% as reports state there are potential tax-related hurdles in its acquisitions by Shire.
KaloBios Pharmaceuticals announced it has filed for a Chapter 11 bankruptcy in the United States Bankruptcy Court for the District of Delaware (Case No. 15-12628).
If it weren’t for bad news, KaloBios would have no news at all.
US Attorney Robert L. Capers announced the arrest of Martin Shkreli today and that he has been and charged with securities fraud conspiracy, securities fraud, and wire fraud conspiracy.
How do you adequately encourage companies to develop such treatments when the market is only a very small number of patients?
Top Orphan Drug Stories for Monday, November 23, 2015
Phase 2 trials in idiopathic pulmonary fibrosis (IPF) and myelofibrosis (MF) to begin in the coming weeks.
"However small the chance might be of striking lucky, the chance was there." ― Roald Dahl, Charlie and the Chocolate Factory
Each year, over 75,000 hospitalizations occur in the United States as a result of vaso-occlusive criss. Andyjr average hospital stay for such a crisis is 6 days.
$vacMongoViewPlus$ $vAR$